Malignant neoplasm of brain stem
ICD-10 C71.7 is a billable code used to indicate a diagnosis of malignant neoplasm of brain stem.
C71.7 refers to malignant neoplasms located in the brain stem, which is a critical area of the central nervous system (CNS) that controls many vital functions, including breathing, heart rate, and blood pressure. Brain stem tumors can be primary, originating from the brain stem itself, or secondary, resulting from metastasis from other parts of the body. Symptoms often include headaches, nausea, vomiting, balance issues, and neurological deficits such as weakness or sensory changes. Imaging studies, particularly MRI, are essential for diagnosis, providing detailed views of the tumor's size, location, and effect on surrounding structures. Molecular markers, such as IDH mutations and 1p/19q co-deletion status, can help in determining the tumor type and guiding treatment options. Treatment typically involves a multidisciplinary approach, including surgery, radiation therapy, and chemotherapy, depending on the tumor's characteristics and the patient's overall health. The prognosis varies significantly based on the tumor type, location, and response to treatment.
Detailed operative reports, imaging studies, and pathology results.
Surgical resection of brain stem tumors, management of post-operative complications.
Accurate coding of surgical procedures and any complications that arise.
Comprehensive treatment plans, including chemotherapy and radiation therapy details.
Management of malignant brain tumors, including palliative care considerations.
Documentation of molecular markers and treatment response is crucial.
Used during surgical intervention for brain stem tumors.
Operative report detailing the procedure and findings.
Neurosurgeons must document the extent of resection and any complications.
Used for post-operative management of brain stem tumors.
Treatment plan and response assessments.
Oncologists must document the type of radiation and dosage.
MRI is the preferred imaging modality for diagnosing brain stem tumors, providing detailed information about the tumor's size, location, and effects on surrounding structures.
Molecular markers can help determine the tumor type and guide treatment options, including targeted therapies and clinical trial eligibility.
